NCT01587703 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 9
- group Id
- BG005
- value
- 32
- group Id
- BG006
- value
- 9
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 10
- group Id
- BG009
- value
- 5
- group Id
- BG010
- value
- 10
- group Id
- BG011
- value
- 12
- units
- Participants
- groups
- description
- Participants were administered once daily oral dose of 4 mg GSK525762
- id
- BG000
- title
- Part 1: GSK525762 4 mg QD
- description
- Participants were administered once daily oral dose of 8 mg GSK525762.
- id
- BG001
- title
- Part 1: GSK525762 8 mg QD
- description
- Participants were administered once daily oral dose of 16 mg GSK525762.
- id
- BG002
- title
- Part 1: GSK525762 16 mg QD
- description
- Participants were administered once daily oral dose of 30 mg GSK525762.
- id
- BG003
- title
- Part 1: GSK525762 30 mg QD
- description
- Participants were administered once daily oral dose of 60 mg GSK525762.
- id
- BG004
- title
- Part 1: GSK525762 60 mg QD
- description
- Participants were administered once daily oral dose of 80 mg GSK525762.
- id
- BG005
- title
- Part 1: GSK525762 80 mg QD
- description
- Participants were administered once daily oral dose of 100 mg GSK525762.
- id
- BG006
- title
- Part 1: GSK525762 100 mg QD
- description
- Participants were administered twice daily (BID) oral dose of 20 mg GSK525762.
- id
- BG007
- title
- Part 1: GSK525762 20 mg BID
- description
- Participants were administered twice daily oral dose of 30 mg GSK525762.
- id
- BG008
- title
- Part 1: GSK525762 30 mg BID
- description
- Participants were administered twice daily oral dose of 40 mg GSK525762.
- id
- BG009
- title
- Part 1: GSK525762 40 mg BID
- description
- All participants who entered besylate sub-study and received 80 mg amor free-base tablet along with 6 mg stable iso in solution in fasted state; 80 mg bes tablet along with 6 mg stable iso in solution in fasted state, 30 mg bes tablet along with 6 mg stable iso in solution in fasted state and 80 mg bes tablet with FDA recommended high fat breakfast in one of the treatment periods were included.
- id
- BG010
- title
- All Participants in Besylate Substudy
- description
- Participants with NUT Midline Carcinoma (NMC) were administered continuous once daily oral dose of 75 mg GSK525762.
- id
- BG011
- title
- Part 2: Participants With NMC
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 19.44
- value
- 47.0
- comment
- Standard deviation could not be calculated as only one participant was analyzed
- group Id
- BG001
- spread
- NA
- value
- 39.0
- group Id
- BG002
- spread
- 4.19
- value
- 53.7
- group Id
- BG003
- spread
- 23.27
- value
- 49.3
- group Id
- BG004
- spread
- 17.06
- value
- 46.7
- group Id
- BG005
- spread
- 16.82
- value
- 51.5
- group Id
- BG006
- spread
- 19.92
- value
- 58.3
- group Id
- BG007
- spread
- 6.45
- value
- 66.5
- group Id
- BG008
- spread
- 8.42
- value
- 63.5
- group Id
- BG009
- spread
- 4.83
- value
- 60.4
- group Id
- BG010
- spread
- 9.96
- value
- 55.2
- group Id
- BG011
- spread
- 18.05
- value
- 42.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 6
- group Id
- BG005
- value
- 14
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 1
- group Id
- BG010
- value
- 5
- group Id
- BG011
- value
- 7
- title
- Female
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 18
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 4
- group Id
- BG010
- value
- 5
- group Id
- BG011
- value
- 5
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 1
- title
- Central/South Asian Heritage (Her)
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 2
- title
- Japanese Her/East Asian Her/South East Asian Her
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 7
- group Id
- BG005
- value
- 30
- group Id
- BG006
- value
- 8
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 10
- group Id
- BG009
- value
- 5
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 6
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 3
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 9
- group Id
- BG005
- value
- 32
- group Id
- BG006
- value
- 9
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 10
- group Id
- BG009
- value
- 5
- group Id
- BG010
- value
- 10
- group Id
- BG011
- value
- 12
- units
- Participants
- groups
- description
- Participants were administered once daily oral dose of 4 mg GSK525762
- id
- BG000
- title
- Part 1: GSK525762 4 mg QD
- description
- Participants were administered once daily oral dose of 8 mg GSK525762.
- id
- BG001
- title
- Part 1: GSK525762 8 mg QD
- description
- Participants were administered once daily oral dose of 16 mg GSK525762.
- id
- BG002
- title
- Part 1: GSK525762 16 mg QD
- description
- Participants were administered once daily oral dose of 30 mg GSK525762.
- id
- BG003
- title
- Part 1: GSK525762 30 mg QD
- description
- Participants were administered once daily oral dose of 60 mg GSK525762.
- id
- BG004
- title
- Part 1: GSK525762 60 mg QD
- description
- Participants were administered once daily oral dose of 80 mg GSK525762.
- id
- BG005
- title
- Part 1: GSK525762 80 mg QD
- description
- Participants were administered once daily oral dose of 100 mg GSK525762.
- id
- BG006
- title
- Part 1: GSK525762 100 mg QD
- description
- Participants were administered twice daily (BID) oral dose of 20 mg GSK525762.
- id
- BG007
- title
- Part 1: GSK525762 20 mg BID
- description
- Participants were administered twice daily oral dose of 30 mg GSK525762.
- id
- BG008
- title
- Part 1: GSK525762 30 mg BID
- description
- Participants were administered twice daily oral dose of 40 mg GSK525762.
- id
- BG009
- title
- Part 1: GSK525762 40 mg BID
- description
- All participants who entered besylate sub-study and received 80 mg amor free-base tablet along with 6 mg stable iso in solution in fasted state; 80 mg bes tablet along with 6 mg stable iso in solution in fasted state, 30 mg bes tablet along with 6 mg stable iso in solution in fasted state and 80 mg bes tablet with FDA recommended high fat breakfast in one of the treatment periods were included.
- id
- BG010
- title
- All Participants in Besylate Substudy
- description
- Participants with NUT Midline Carcinoma (NMC) were administered continuous once daily oral dose of 75 mg GSK525762.
- id
- BG011
- title
- Part 2: Participants With NMC
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 19.44
- value
- 47.0
- comment
- Standard deviation could not be calculated as only one participant was analyzed
- group Id
- BG001
- spread
- NA
- value
- 39.0
- group Id
- BG002
- spread
- 4.19
- value
- 53.7
- group Id
- BG003
- spread
- 23.27
- value
- 49.3
- group Id
- BG004
- spread
- 17.06
- value
- 46.7
- group Id
- BG005
- spread
- 16.82
- value
- 51.5
- group Id
- BG006
- spread
- 19.92
- value
- 58.3
- group Id
- BG007
- spread
- 6.45
- value
- 66.5
- group Id
- BG008
- spread
- 8.42
- value
- 63.5
- group Id
- BG009
- spread
- 4.83
- value
- 60.4
- group Id
- BG010
- spread
- 9.96
- value
- 55.2
- group Id
- BG011
- spread
- 18.05
- value
- 42.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 6
- group Id
- BG005
- value
- 14
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 1
- group Id
- BG010
- value
- 5
- group Id
- BG011
- value
- 7
- title
- Female
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 18
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 4
- group Id
- BG010
- value
- 5
- group Id
- BG011
- value
- 5
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 1
- title
- Central/South Asian Heritage (Her)
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 2
- title
- Japanese Her/East Asian Her/South East Asian Her
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 7
- group Id
- BG005
- value
- 30
- group Id
- BG006
- value
- 8
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 10
- group Id
- BG009
- value
- 5
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 6
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 3
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle